body{font-family:arial} h1,h2,h3,h4,h5,h6,h7,h8{font-family: arial} :link{color:(#7f7f56);}/*for unvisited links*/ :visited{color:(#ffffac);}/*for visited links*/ -->

Monday, July 23, 2012

CADUET AND DIABETES

Two factors that influence CV risk the most in diabetics include HTN and hyperlipidemia. Caduet contains amlodipine for BP and atorvastatin for lipid reduction. Clinical trials have demonstrated efficacy of atorvastatin in CV protection in diabetics REGARDLESS of baseline lipid levels.

POSTED BY:  STEVEN AJLUNI, MD

No comments:

Post a Comment